...
首页> 外文期刊>Current opinion in pharmacology >Role of the P2X7 receptor in the pathogenesis of type 2 diabetes and its microvascular complications
【24h】

Role of the P2X7 receptor in the pathogenesis of type 2 diabetes and its microvascular complications

机译:P2X7受体在2型糖尿病发病机制中的作用及其微血管并发症

获取原文
获取原文并翻译 | 示例
           

摘要

P2X7 receptors can be found in many tissues and organs, where they mediate several biological functions. This review summarizes the current knowledge about the role of this receptor in the pathogenesis of type 2 diabetes, in which the key clinical features are impaired insulin secretion and sensitivity, hyperglycemia, coexistence of other cardiovascular risk factors such as dyslipidemia and hypertension, and subclinical inflammation. The receptor modulates crucial pathways in the pancreatic islets (where it can either exert a trophic or detrimental action on beta cells), and in the liver, in the adipose tissue and in the skeletal muscle, which are main sites of insulin resistance. P2X7 receptors also modulate a series of inflammatory responses that participate in the development of the microvascular complications of the disease. Potent and selective P2X7R blockers are available to be tested in Phase I/II clinical studies for the treatment of several chronic diseases, and it might be worthwhile to consider inclusion of patients with type 2 diabetes and its complications.
机译:P2X7受体可以在许多组织和器官中发现,在那里他们介导几种生物学功能。本综述总结了目前关于该受体在2型糖尿病发病机制中的作用的知识,其中关键的临床特征受损胰岛素分泌和敏感性,高血糖,其他心血管危险因素,如血脂血症和高血压,以及亚临床炎症。受体调节胰岛胰岛中的关键途径(它可以在β细胞上施加营养或有害作用),并且在脂肪组织中和骨骼肌中,骨骼肌中是胰岛素抵抗的主要部位。 P2X7受体还调节一系列参与疾病的微血管并发症的发展的炎症反应。有效和选择性P2X7R阻滞剂可用于治疗几种慢性疾病的阶段I / II临床研究中,可以考虑包含2型糖尿病患者及其并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号